Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028
The global brain monitoring market size is estimated to be USD 4.8 billion by 2028, from USD 3.5 billion in 2023, at a CAGR of 6.3%. The brain monitoring market experiences propulsion primarily due to heightened occurrences of neurological disorders, increased awareness regarding neurodegenerative diseases, a surge in traumatic brain injuries, and amplified utilization of brain monitoring in clinical trials. Moreover, the market is set to benefit from escalating demands for non-invasive and minimally invasive devices, the expanding spectrum of therapeutic applications for brain monitoring tools, and the burgeoning healthcare sector in emerging economies. Conversely, challenges such as the high expenses associated with complex brain monitoring procedures and devices, unfavorable reimbursement policies, and a shortage of proficient professionals capable of effectively operating brain monitoring devices impede the market's growth.
“The devices segment is expected to account for the largest brain monitoring devices market share in 2022.”
By product, the global brain monitoring market is categorized into devices and accessories. The devices segment is expected to hold the largest share of the brain monitoring market in 2022. This is primarily attributed to the increasing occurrence of neurological, neurodegenerative, psychotic, and sleep disorders, alongside the imperative for early diagnosis, the presence of innovative portable and wearable monitoring devices designed for home use, and a growing awareness among patients.
“The electrodes segment to register the highest growth rate in the forecast period.”
The electrodes segment is expected to register the highest growth rate in the forecast period. Technological progress has improved electrode-tissue interfaces, enabling the creation of cost-efficient, high-functioning electrodes within this market. Moreover, the integration of disposable electrodes has significantly propelled their acceptance and the expansion of this market segment.
“The Fixed devices accounted for the largest share of the modality segment of the brain monitoring market.”
By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. Attributed to their established utilization in clinical environments like hospitals, specialized healthcare centers, and research institutions, these fixed devices are commonly regarded as the benchmark for comprehensive brain monitoring. Their reputation stems from their precision, dependability, and sophisticated features.
The traumatic brain injury segment accounted for the largest share of the brain monitoring market in 2022.
Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A key factor substantially boosting the market share of this segment is the notable rise in Traumatic Brain Injuries (TBIs) worldwide. This escalation in TBIs generates a considerable need for managing these cases, thereby requiring the widespread use of brain monitoring devices.
“North America to be the largest regional segment in the brain monitoring market during the forecast period.”
Based on the region, the global brain monitoring market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the global brain monitoring market in 2022, while Asia Pacific is projected to be the fastest-growing region in the forecast period. The expansion of the market in Asia stems from several factors, including the expanding elderly population, access to affordable skilled labor, rising disposable incomes, an increased incidence of neurodegenerative disorders, and heightened governmental focus on healthcare reforms within the region.
Breakdown of primaries
The break of primary participants was as mentioned below:
Research Coverage:
The report segments the brain monitoring market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (devices and accessories), Procedure (Invasive, non-invasive), Modality (Fixed, Wearable, Portable), disease type (traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases), end-user (into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end-users),
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the Brain Monitoring market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Brain Monitoring market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
.
“The devices segment is expected to account for the largest brain monitoring devices market share in 2022.”
By product, the global brain monitoring market is categorized into devices and accessories. The devices segment is expected to hold the largest share of the brain monitoring market in 2022. This is primarily attributed to the increasing occurrence of neurological, neurodegenerative, psychotic, and sleep disorders, alongside the imperative for early diagnosis, the presence of innovative portable and wearable monitoring devices designed for home use, and a growing awareness among patients.
“The electrodes segment to register the highest growth rate in the forecast period.”
The electrodes segment is expected to register the highest growth rate in the forecast period. Technological progress has improved electrode-tissue interfaces, enabling the creation of cost-efficient, high-functioning electrodes within this market. Moreover, the integration of disposable electrodes has significantly propelled their acceptance and the expansion of this market segment.
“The Fixed devices accounted for the largest share of the modality segment of the brain monitoring market.”
By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. Attributed to their established utilization in clinical environments like hospitals, specialized healthcare centers, and research institutions, these fixed devices are commonly regarded as the benchmark for comprehensive brain monitoring. Their reputation stems from their precision, dependability, and sophisticated features.
The traumatic brain injury segment accounted for the largest share of the brain monitoring market in 2022.
Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A key factor substantially boosting the market share of this segment is the notable rise in Traumatic Brain Injuries (TBIs) worldwide. This escalation in TBIs generates a considerable need for managing these cases, thereby requiring the widespread use of brain monitoring devices.
“North America to be the largest regional segment in the brain monitoring market during the forecast period.”
Based on the region, the global brain monitoring market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the global brain monitoring market in 2022, while Asia Pacific is projected to be the fastest-growing region in the forecast period. The expansion of the market in Asia stems from several factors, including the expanding elderly population, access to affordable skilled labor, rising disposable incomes, an increased incidence of neurodegenerative disorders, and heightened governmental focus on healthcare reforms within the region.
Breakdown of primaries
The break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Research Coverage:
The report segments the brain monitoring market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (devices and accessories), Procedure (Invasive, non-invasive), Modality (Fixed, Wearable, Portable), disease type (traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases), end-user (into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end-users),
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the Brain Monitoring market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Brain Monitoring market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
.
- Analysis of key drivers (increasing incidence and prevalence of neurological disorders, rising awareness of neurogenerative disorders, growing incidence of traumatic brain injuries), restraints (high cost of complex brain monitoring procedures and devices, unfavorable reimbursement policies), opportunities (increasing demand of non-invasive and minimally invasive devices), challenges (the shortage of trained professionals to effectively operate brain monitoring devices).
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global brain monitoring market. The report analyzes this market by products, procedure, modality, medical condition, and end users.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global brain monitoring market
- Market Development: Comprehensive information on the lucrative emerging markets by products, procedure, modality, medical condition, and end users.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global brain monitoring market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global brain monitoring market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
1.4.2 REGIONS COVERED
FIGURE 2 REGIONAL SEGMENTATION
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 RESEARCH LIMITATIONS
1.6.1 SCOPE-RELATED LIMITATIONS
1.6.2 METHODOLOGY-RELATED LIMITATIONS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 COMPANY REVENUE ESTIMATION: NATUS MEDICAL, INC. (2022)
FIGURE 9 MARKET REVENUE ESTIMATION: EEG MARKET
FIGURE 10 BOTTOM-UP APPROACH
FIGURE 11 TOP-DOWN APPROACH
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN MONITORING MARKET (2023–2028)
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
TABLE 1 MARKET ASSESSMENT FACTOR ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 14 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: BRAIN MONITORING MARKET
2.6 IMPACT OF ECONOMIC RECESSION ON BRAIN MONITORING MARKET
3 EXECUTIVE SUMMARY
FIGURE 15 BRAIN MONITORING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 16 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 BRAIN MONITORING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)
FIGURE 18 BRAIN MONITORING MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 19 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION)
FIGURE 20 BRAIN MONITORING MARKET, BY END USER, 2023–2028 (USD MILLION)
FIGURE 21 REGIONAL SNAPSHOT: BRAIN MONITORING MARKET
4 PREMIUM INSIGHTS
4.1 BRAIN MONITORING MARKET OVERVIEW
FIGURE 22 INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
4.2 BRAIN MONITORING MARKET, BY REGION
FIGURE 23 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
4.3 BRAIN MONITORING MARKET, BY PROCEDURE
FIGURE 24 NON-INVASIVE PROCEDURES AND JAPAN HELD LARGEST MARKET SHARE IN 2022
4.4 GEOGRAPHIC SNAPSHOT: BRAIN MONITORING MARKET
FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
4.5 DEVELOPED VS. EMERGING ECONOMIES: BRAIN MONITORING MARKET
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 27 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BRAIN MONITORING MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing incidence and prevalence of neurological disorders
5.2.1.2 Rising awareness of neurodegenerative disorders
5.2.1.3 Growing incidence of traumatic brain injuries
5.2.1.4 Increased applications of brain monitoring devices in clinical trials
5.2.2 RESTRAINTS
5.2.2.1 High cost of complex brain monitoring procedures and devices
5.2.2.2 Unfavorable reimbursement policies
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for non-invasive and minimally-invasive brain monitoring devices
5.2.3.2 Expanding therapeutic applications of brain monitoring devices
5.2.3.3 Growing healthcare market in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of trained medical professionals
5.2.4.2 Complex regulatory process and compliance framework
5.3 INDUSTRY TRENDS
5.3.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
5.3.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY
5.4 PRICING ANALYSIS
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING DEVICES
TABLE 4 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2022)
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH & PRODUCT DEVELOPMENT
5.5.2 RAW MATERIAL PROCUREMENT
5.5.3 MANUFACTURING
5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 28 VALUE CHAIN ANALYSIS: BRAIN MONITORING MARKET
5.6 ECOSYSTEM MARKET/MAP
FIGURE 29 ECOSYSTEM MARKET/MAP: BRAIN MONITORING MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PORTER’S FIVE FORCES ANALYSIS: BRAIN MONITORING MARKET
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 TARIFF & REGULATORY ANALYSIS
5.8.1 TARIFF FOR BRAIN MONITORING DEVICES
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 REGULATORY ANALYSIS
5.8.3.1 North America
5.8.3.1.1 US
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.3.1.2 Canada
5.8.3.2 Europe
5.8.3.3 Asia Pacific
5.8.3.3.1 Japan
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.8.3.3.2 China
5.8.3.3.3 India
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS, 2011–2023
5.10.3 MAJOR PATENTS IN BRAIN MONITORING MARKET
FIGURE 31 MAJOR PATENTS FOR BRAIN MONITORING DEVICES (2011–2023)
5.11 TRADE ANALYSIS
FIGURE 32 PRODUCT IMPORTS UNDER HSN CODE: 901819, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 33 PRODUCT EXPORTS UNDER HSN CODE 901819, BY COUNTRY, 2022 (USD THOUSAND)
5.12 CASE STUDY ANALYSIS
TABLE 10 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA DIRECTLY INTO MEDTRONIC CARE MANAGEMENT SERVICES' (MCMS) BRAIN MONITORING PLATFORM
TABLE 11 CASE STUDY 2: EPI-MINDER: A NOVEL IMPLANTABLE DEVICE FOR EPILEPSY MONITORING AND PREDICTION
5.13 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 12 LIST OF KEY CONFERENCES & EVENTS IN BRAIN MONITORING MARKET, 2023–2024
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES AND ACCESSORIES, BY TYPE
5.14.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES, BY TYPE
TABLE 15 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES
5.15 UNMET NEEDS ANALYSIS & END USER EXPECTATIONS
TABLE 16 UNMET NEEDS IN BRAIN MONITORING MARKET
5.15.1 END USER EXPECTATIONS
TABLE 17 END USER EXPECTATIONS IN BRAIN MONITORING MARKET
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 35 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR BRAIN MONITORING MARKET
5.17 REIMBURSEMENT SCENARIO ANALYSIS
TABLE 18 CPT CODES AND REIMBURSEMENT ANALYSIS IN BRAIN MONITORING MARKET IN US
5.18 BUSINESS MODEL ANALYSIS
5.19 INVESTMENT AND FUNDING SCENARIO
FIGURE 36 INVESTOR DEALS AND FUNDING FOR BRAIN MONITORING DEVICES INCREASED IN 2022
FIGURE 37 VALUATION OF KEY FIRMS IN BRAIN MONITORING MARKET IN 2022 (USD MILLION)
6 BRAIN MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 19 BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 DEVICES
TABLE 20 BRAIN MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
6.2.1 EEG DEVICES
6.2.1.1 Growing R&D in cerebral and spinal disorders and increasing number of EEG laboratories to drive segment
TABLE 22 EEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 TCD DEVICES
6.2.2.1 Rising prevalence of strokes and cerebrovascular disorders to aid market growth
TABLE 23 TCD DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 MEG DEVICES
6.2.3.1 High implementation and maintenance costs to limit market
TABLE 24 MEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 ICP MONITORS
6.2.4.1 Increasing incidence of traumatic brain injuries and post-surgical cerebrovascular complications to propel market
TABLE 25 ICP MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 CEREBRAL OXIMETERS
6.2.5.1 Increasing cases of hypoxia during surgical procedures to drive segment
TABLE 26 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 MRI SCANNERS
6.2.6.1 Technological advancements and rising number of neurological disorders to propel segment
TABLE 27 MRI SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.7 CT SCANNERS
6.2.7.1 Increasing preference for brain disease progression monitoring to drive segment
TABLE 28 CT SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.8 PET SCANNERS
6.2.8.1 Rising incidence of cancer to support market growth
TABLE 29 PET SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.9 SLEEP MONITORING DEVICES
6.2.9.1 Rising prevalence of sleep disorders to boost market growth
TABLE 30 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.10 EMG DEVICES
6.2.10.1 Increasing prevalence of neuromuscular diseases to aid market growth
TABLE 31 EMG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 ACCESSORIES
TABLE 32 BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE
TABLE 33 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
6.3.1.1 Electrodes
TABLE 34 ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.1 Wet electrodes
6.3.1.1.1.1 Flexibility and high quality of signal recording to drive segment
TABLE 35 WET ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.2 Dry electrodes
6.3.1.1.2.1 Technological advancements and no requirement for skin preparation to aid market growth
TABLE 36 DRY ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.3 Needle electrodes
6.3.1.1.3.1 More accurate signals for diagnostic and therapeutic interventions to support market growth
TABLE 37 NEEDLE ELECTRODES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.2 Sensors
6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive market
TABLE 38 SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.3 Pastes & gels
6.3.1.3.1 Increasing demand for non-invasive methods of brain monitoring to aid market growth
TABLE 39 PASTES & GELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.4 Caps
6.3.1.4.1 Extended application of Infacaps for premature babies to propel segment
TABLE 40 CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.5 Batteries
6.3.1.5.1 Increasing usage of portable and rechargeable devices to support segment growth
TABLE 41 BATTERIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.6 Cables
6.3.1.6.1 Technological developments for increasing capabilities and cable lifespan to drive segment
TABLE 42 CABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.7 Other accessories
TABLE 43 OTHER ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY
TABLE 44 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
6.3.2.1 Disposable accessories
6.3.2.1.1 Growing physician preference for disposable accessories to propel market
TABLE 45 DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2.2 Non-disposable accessories
6.3.2.2.1 Increased usage of reusable accessories in emerging economies to boost segment growth
TABLE 46 NON-DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 BRAIN MONITORING MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 47 BRAIN MONITORING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.1.1 NON-INVASIVE PROCEDURES
7.1.1.1 Limited risk of infections and hemorrhage to drive market
TABLE 48 BRAIN MONITORING MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
7.1.2 INVASIVE PROCEDURES
7.1.2.1 Higher resolution imaging and detailed disease information to propel market
TABLE 49 BRAIN MONITORING MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
8 BRAIN MONITORING MARKET, BY MODALITY
8.1 INTRODUCTION
TABLE 50 BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
8.2 FIXED DEVICES
8.2.1 HIGH ACCURACY, MORE RELIABILITY, AND BETTER DIAGNOSIS TO AID MARKET GROWTH
TABLE 51 BRAIN MONITORING MARKET FOR FIXED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 PORTABLE DEVICES
8.3.1 INCREASED MOBILITY AND COMFORT TO PROPEL MARKET GROWTH
TABLE 52 BRAIN MONITORING MARKET FOR PORTABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 WEARABLE DEVICES
8.4.1 GREATER CONVENIENCE AND CONTINUOUS DATA COLLECTION TO DRIVE MARKET GROWTH
TABLE 53 BRAIN MONITORING MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
9 BRAIN MONITORING MARKET, BY MEDICAL CONDITION
9.1 INTRODUCTION
TABLE 54 COMPANIES OFFERING DEVICES FOR DIFFERENT MEDICAL CONDITIONS
TABLE 55 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
9.2 TRAUMATIC BRAIN INJURY
9.2.1 GROWING INCIDENCE ACROSS ALL AGE GROUPS TO DRIVE MARKET
TABLE 56 BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 STROKE
9.3.1 GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH
TABLE 57 BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 DEMENTIA
9.4.1 FAVORABLE GOVERNMENT INITIATIVES AND INCREASED ACCESS TO TREATMENT TO DRIVE MARKET
TABLE 58 BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 HEADACHE DISORDERS
9.5.1 RISING NUMBER OF INITIATIVES FOR HEADACHE DISORDERS TO PROPEL MARKET
TABLE 59 BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 SLEEP DISORDERS
9.6.1 INCREASED STRESS AND UNHEALTHY LIFESTYLES AMONG ADULTS TO DRIVE MARKET
TABLE 60 BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.7 PARKINSON’S DISEASE
9.7.1 INCREASING GERIATRIC POPULATION TO AID MARKET GROWTH
TABLE 61 BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
9.8 EPILEPSY
9.8.1 RISING OCCURRENCE OF EPILEPSY AMONG ALL AGE GROUPS TO SUPPORT MARKET GROWTH
TABLE 62 BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2021–2028 (USD MILLION)
9.9 HUNTINGTON’S DISEASE
9.9.1 AVAILABILITY OF ADVANCED TREATMENT AND ONGOING RESEARCH TO AID MARKET GROWTH
TABLE 63 BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
9.10 OTHER MEDICAL CONDITIONS
TABLE 64 BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 BRAIN MONITORING MARKET, BY END USER
10.1 INTRODUCTION
TABLE 65 BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS
10.2.1 HOSPITALS TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
TABLE 66 BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 NEUROLOGY CENTERS
10.3.1 PRESENCE OF HIGHLY EFFICIENT AND ADVANCED BRAIN MONITORING DEVICES TO PROPEL MARKET
TABLE 67 BRAIN MONITORING MARKET FOR NEUROLOGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 DIAGNOSTIC CENTERS
10.4.1 FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF NEUROGENERATIVE DISORDERS TO SUPPORT MARKET GROWTH
TABLE 68 BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
10.5 AMBULATORY SURGERY CENTERS & CLINICS
10.5.1 COST-EFFECTIVE AND MORE CONVENIENT TREATMENT OPTIONS TO AID MARKET GROWTH
TABLE 69 BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
10.6 OTHER END USERS
TABLE 70 BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
11 BRAIN MONITORING MARKET, BY REGION
11.1 INTRODUCTION
TABLE 71 BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT
TABLE 72 NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 74 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 79 NORTH AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 80 NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 US to dominate North American brain monitoring market during forecast period
TABLE 82 US: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 83 US: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 US: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 87 US: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 88 US: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 89 US: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 90 US: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Increasing number of hospitals and surgical centers to propel market
TABLE 91 CANADA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 93 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CANADA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 96 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 97 CANADA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 CANADA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 99 CANADA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 EUROPE
FIGURE 39 EUROPE: BRAIN MONITORING MARKET SNAPSHOT
TABLE 100 EUROPE: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 106 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.1 EUROPE: RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Growing geriatric population and increasing life expectancy to aid market growth
TABLE 110 GERMANY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 111 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 115 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 116 GERMANY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 117 GERMANY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 118 GERMANY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increasing prevalence of neurological disorders to drive market
TABLE 119 FRANCE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 124 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 125 FRANCE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 126 FRANCE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 127 FRANCE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.4 UK
11.3.4.1 Increasing R&D investments by public and private sectors to boost market growth
TABLE 128 UK: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 UK: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 UK: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 133 UK: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 134 UK: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 135 UK: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 136 UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Rising incidence of neurological disorders in aging population to drive market
TABLE 137 ITALY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 138 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 ITALY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 142 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 143 ITALY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 144 ITALY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 145 ITALY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increased burden of Parkinson’s disease to propel market
TABLE 146 SPAIN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 147 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 SPAIN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 154 SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 155 REST OF EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 156 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 159 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 160 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 161 REST OF EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 162 REST OF EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 164 ASIA PACIFIC: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 172 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 173 ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.1 ASIA PACIFIC: RECESSION IMPACT
11.4.2 JAPAN
11.4.2.1 High incidence of neurological disorders and large geriatric population to drive market
TABLE 174 JAPAN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 175 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 JAPAN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 179 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 180 JAPAN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 181 JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 182 JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Increasing number of government initiatives and growing incidence of neurological disorders to drive market
TABLE 183 CHINA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 184 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 CHINA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 188 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 189 CHINA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 190 CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 191 CHINA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Improving healthcare infrastructure and rising public-private investment to support market growth
TABLE 192 INDIA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 193 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 INDIA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 197 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 198 INDIA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 199 INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 200 INDIA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 201 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 REST OF ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 LATIN AMERICA
TABLE 210 LATIN AMERICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 211 LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 212 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 216 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 217 LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 218 LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 219 LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.1 LATIN AMERICA: RECESSION IMPACT
11.5.2 BRAZIL
11.5.2.1 High cost of brain monitoring and imaging modalities to limit market growth
TABLE 220 BRAZIL: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 221 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 223 BRAZIL: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 224 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 225 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 226 BRAZIL: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 227 BRAZIL: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 228 BRAZIL: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Low tax rates and strong healthcare infrastructure to support market growth
TABLE 229 MEXICO: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 230 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 MEXICO: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 234 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 235 MEXICO: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 236 MEXICO: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 237 MEXICO: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 238 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 239 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 243 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 244 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 245 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 246 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
TABLE 247 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 249 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 253 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 254 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 255 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 256 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
11.6.2 GCC COUNTRIES
11.6.2.1 Rising prevalence of Alzheimer’s and increasing number of government initiatives to drive market
TABLE 257 GCC COUNTRIES: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 258 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 GCC COUNTRIES: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 262 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 263 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 264 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 265 GCC COUNTRIES: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 266 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 267 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 REST OF MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 271 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 272 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 273 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 274 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY STRATEGIES/RIGHT TO WIN
TABLE 275 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAIN MONITORING MARKET
12.3 REVENUE SHARE ANALYSIS
12.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 276 DEGREE OF COMPETITION IN BRAIN MONITORING MARKET
FIGURE 42 RANKING OF KEY COMPANIES IN BRAIN MONITORING MARKET, 2022
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 43 COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT
12.5.5.1 Overall footprint
TABLE 277 BRAIN MONITORING MARKET: OVERALL FOOTPRINT
12.5.5.2 Product footprint
TABLE 278 BRAIN MONITORING MARKET: PRODUCT FOOTPRINT
12.5.5.3 Procedure footprint
TABLE 279 BRAIN MONITORING MARKET: PROCEDURE FOOTPRINT
12.5.5.4 Modality footprint
TABLE 280 BRAIN MONITORING MARKET: MODALITY FOOTPRINT
12.5.5.5 Medical condition footprint
TABLE 281 BRAIN MONITORING MARKET: MEDICAL CONDITION FOOTPRINT
12.5.5.6 End user footprint
TABLE 282 BRAIN MONITORING MARKET: END USER FOOTPRINT
12.5.5.7 Regional footprint
TABLE 283 BRAIN MONITORING MARKET: REGIONAL FOOTPRINT
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 44 START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 284 DETAILED LIST OF KEY START-UPS/SMES IN BRAIN MONITORING MARKET
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 285 BRAIN MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2024
12.7.2 DEALS
TABLE 286 BRAIN MONITORING MARKET: DEALS, 2020–2024
12.7.3 OTHER DEVELOPMENTS
TABLE 287 BRAIN MONITORING MARKET: OTHER DEVELOPMENTS, 2020–2024
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 NATUS MEDICAL INCORPORATED
TABLE 289 NATUS MEDICAL INCORPORATED: DEALS, 2020–2024
13.1.2 NIHON KOHDEN CORPORATION
TABLE 290 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 291 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES &
APPROVALS, 2020–2024
13.1.3 PHILIPS HEALTHCARE
TABLE 292 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 293 PHILIPS HEALTHCARE: DEALS, 2020–2024
13.1.4 GE HEALTHCARE
TABLE 294 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 47 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 295 GE HEALTHCARE: DEALS, 2020–2024
13.1.5 SIEMENS HEALTHINEERS AG
TABLE 296 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 48 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
TABLE 297 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 298 SIEMENS HEALTHINEERS AG: DEALS, 2020–2024
13.1.6 COMPUMEDICS LIMITED
TABLE 299 COMPUMEDICS LIMITED: COMPANY OVERVIEW
FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)
TABLE 300 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 301 COMPUMEDICS LIMITED: DEALS, 2020–2024
13.1.7 MEDTRONIC
TABLE 302 MEDTRONIC: COMPANY OVERVIEW
FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2023)
13.1.8 EDWARDS LIFESCIENCES CORPORATION
TABLE 303 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 51 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
13.1.9 ADVANCED BRAIN MONITORING, INC.
TABLE 304 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW
13.1.10 CADWELL INDUSTRIES, INC.
TABLE 305 CADWELL INDUSTRIES, INC: COMPANY OVERVIEW
TABLE 306 CADWELL INDUSTRIES, INC.: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 307 CADWELL INDUSTRIES, INC.: DEALS, 2020–2024
13.1.11 NEUROWAVE SYSTEMS, INC.
TABLE 308 NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW
13.1.12 NEUROSOFT
TABLE 309 NEUROSOFT: COMPANY OVERVIEW
13.1.13 CGX
TABLE 310 CGX: COMPANY OVERVIEW
TABLE 311 CGX: OTHER DEVELOPMENTS, 2020–2024
13.1.14 NONIN
TABLE 312 NONIN: COMPANY OVERVIEW
13.1.15 RIMED
TABLE 313 RIMED: COMPANY OVERVIEW
TABLE 314 RIMED: DEALS, 2020–2024
13.1.16 EMOTIV
TABLE 315 EMOTIV: COMPANY OVERVIEW
13.1.17 DRДGERWERK AG & CO. KGAA
TABLE 316 DRДGERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 52 DRДGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
13.1.18 MASIMO CORPORATION
TABLE 317 MASIMO CORPORATION: COMPANY OVERVIEW
FIGURE 53 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 318 MASIMO CORPORATION: DEALS, 2020–2024
13.1.19 LUCIOLE MEDICAL AG
TABLE 319 LUCIOLE MEDICAL AG: COMPANY OVERVIEW
TABLE 320 LUCIOLE MEDICAL AG: DEALS, 2020–2024
13.1.20 INTEGRA LIFESCIENCES
TABLE 321 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
FIGURE 54 INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022)
13.2 OTHER PLAYERS
13.2.1 INFRASCAN, INC.
13.2.2 NEUSOFT MEDICAL SYSTEMS CO., LTD.
13.2.3 NORAXON USA
13.2.4 STERNMED GMBH
13.2.5 CERIBELL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
1.4.2 REGIONS COVERED
FIGURE 2 REGIONAL SEGMENTATION
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 RESEARCH LIMITATIONS
1.6.1 SCOPE-RELATED LIMITATIONS
1.6.2 METHODOLOGY-RELATED LIMITATIONS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 COMPANY REVENUE ESTIMATION: NATUS MEDICAL, INC. (2022)
FIGURE 9 MARKET REVENUE ESTIMATION: EEG MARKET
FIGURE 10 BOTTOM-UP APPROACH
FIGURE 11 TOP-DOWN APPROACH
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN MONITORING MARKET (2023–2028)
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
TABLE 1 MARKET ASSESSMENT FACTOR ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 14 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: BRAIN MONITORING MARKET
2.6 IMPACT OF ECONOMIC RECESSION ON BRAIN MONITORING MARKET
3 EXECUTIVE SUMMARY
FIGURE 15 BRAIN MONITORING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 16 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 BRAIN MONITORING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)
FIGURE 18 BRAIN MONITORING MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 19 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION)
FIGURE 20 BRAIN MONITORING MARKET, BY END USER, 2023–2028 (USD MILLION)
FIGURE 21 REGIONAL SNAPSHOT: BRAIN MONITORING MARKET
4 PREMIUM INSIGHTS
4.1 BRAIN MONITORING MARKET OVERVIEW
FIGURE 22 INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
4.2 BRAIN MONITORING MARKET, BY REGION
FIGURE 23 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
4.3 BRAIN MONITORING MARKET, BY PROCEDURE
FIGURE 24 NON-INVASIVE PROCEDURES AND JAPAN HELD LARGEST MARKET SHARE IN 2022
4.4 GEOGRAPHIC SNAPSHOT: BRAIN MONITORING MARKET
FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
4.5 DEVELOPED VS. EMERGING ECONOMIES: BRAIN MONITORING MARKET
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 27 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BRAIN MONITORING MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing incidence and prevalence of neurological disorders
5.2.1.2 Rising awareness of neurodegenerative disorders
5.2.1.3 Growing incidence of traumatic brain injuries
5.2.1.4 Increased applications of brain monitoring devices in clinical trials
5.2.2 RESTRAINTS
5.2.2.1 High cost of complex brain monitoring procedures and devices
5.2.2.2 Unfavorable reimbursement policies
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for non-invasive and minimally-invasive brain monitoring devices
5.2.3.2 Expanding therapeutic applications of brain monitoring devices
5.2.3.3 Growing healthcare market in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of trained medical professionals
5.2.4.2 Complex regulatory process and compliance framework
5.3 INDUSTRY TRENDS
5.3.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
5.3.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY
5.4 PRICING ANALYSIS
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING DEVICES
TABLE 4 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2022)
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH & PRODUCT DEVELOPMENT
5.5.2 RAW MATERIAL PROCUREMENT
5.5.3 MANUFACTURING
5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 28 VALUE CHAIN ANALYSIS: BRAIN MONITORING MARKET
5.6 ECOSYSTEM MARKET/MAP
FIGURE 29 ECOSYSTEM MARKET/MAP: BRAIN MONITORING MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PORTER’S FIVE FORCES ANALYSIS: BRAIN MONITORING MARKET
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 TARIFF & REGULATORY ANALYSIS
5.8.1 TARIFF FOR BRAIN MONITORING DEVICES
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 REGULATORY ANALYSIS
5.8.3.1 North America
5.8.3.1.1 US
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.3.1.2 Canada
5.8.3.2 Europe
5.8.3.3 Asia Pacific
5.8.3.3.1 Japan
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.8.3.3.2 China
5.8.3.3.3 India
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS, 2011–2023
5.10.3 MAJOR PATENTS IN BRAIN MONITORING MARKET
FIGURE 31 MAJOR PATENTS FOR BRAIN MONITORING DEVICES (2011–2023)
5.11 TRADE ANALYSIS
FIGURE 32 PRODUCT IMPORTS UNDER HSN CODE: 901819, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 33 PRODUCT EXPORTS UNDER HSN CODE 901819, BY COUNTRY, 2022 (USD THOUSAND)
5.12 CASE STUDY ANALYSIS
TABLE 10 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA DIRECTLY INTO MEDTRONIC CARE MANAGEMENT SERVICES' (MCMS) BRAIN MONITORING PLATFORM
TABLE 11 CASE STUDY 2: EPI-MINDER: A NOVEL IMPLANTABLE DEVICE FOR EPILEPSY MONITORING AND PREDICTION
5.13 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 12 LIST OF KEY CONFERENCES & EVENTS IN BRAIN MONITORING MARKET, 2023–2024
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES AND ACCESSORIES, BY TYPE
5.14.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES, BY TYPE
TABLE 15 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES
5.15 UNMET NEEDS ANALYSIS & END USER EXPECTATIONS
TABLE 16 UNMET NEEDS IN BRAIN MONITORING MARKET
5.15.1 END USER EXPECTATIONS
TABLE 17 END USER EXPECTATIONS IN BRAIN MONITORING MARKET
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 35 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR BRAIN MONITORING MARKET
5.17 REIMBURSEMENT SCENARIO ANALYSIS
TABLE 18 CPT CODES AND REIMBURSEMENT ANALYSIS IN BRAIN MONITORING MARKET IN US
5.18 BUSINESS MODEL ANALYSIS
5.19 INVESTMENT AND FUNDING SCENARIO
FIGURE 36 INVESTOR DEALS AND FUNDING FOR BRAIN MONITORING DEVICES INCREASED IN 2022
FIGURE 37 VALUATION OF KEY FIRMS IN BRAIN MONITORING MARKET IN 2022 (USD MILLION)
6 BRAIN MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 19 BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 DEVICES
TABLE 20 BRAIN MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
6.2.1 EEG DEVICES
6.2.1.1 Growing R&D in cerebral and spinal disorders and increasing number of EEG laboratories to drive segment
TABLE 22 EEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 TCD DEVICES
6.2.2.1 Rising prevalence of strokes and cerebrovascular disorders to aid market growth
TABLE 23 TCD DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 MEG DEVICES
6.2.3.1 High implementation and maintenance costs to limit market
TABLE 24 MEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 ICP MONITORS
6.2.4.1 Increasing incidence of traumatic brain injuries and post-surgical cerebrovascular complications to propel market
TABLE 25 ICP MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 CEREBRAL OXIMETERS
6.2.5.1 Increasing cases of hypoxia during surgical procedures to drive segment
TABLE 26 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 MRI SCANNERS
6.2.6.1 Technological advancements and rising number of neurological disorders to propel segment
TABLE 27 MRI SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.7 CT SCANNERS
6.2.7.1 Increasing preference for brain disease progression monitoring to drive segment
TABLE 28 CT SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.8 PET SCANNERS
6.2.8.1 Rising incidence of cancer to support market growth
TABLE 29 PET SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.9 SLEEP MONITORING DEVICES
6.2.9.1 Rising prevalence of sleep disorders to boost market growth
TABLE 30 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.10 EMG DEVICES
6.2.10.1 Increasing prevalence of neuromuscular diseases to aid market growth
TABLE 31 EMG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 ACCESSORIES
TABLE 32 BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE
TABLE 33 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
6.3.1.1 Electrodes
TABLE 34 ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.1 Wet electrodes
6.3.1.1.1.1 Flexibility and high quality of signal recording to drive segment
TABLE 35 WET ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.2 Dry electrodes
6.3.1.1.2.1 Technological advancements and no requirement for skin preparation to aid market growth
TABLE 36 DRY ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.1.3 Needle electrodes
6.3.1.1.3.1 More accurate signals for diagnostic and therapeutic interventions to support market growth
TABLE 37 NEEDLE ELECTRODES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.2 Sensors
6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive market
TABLE 38 SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.3 Pastes & gels
6.3.1.3.1 Increasing demand for non-invasive methods of brain monitoring to aid market growth
TABLE 39 PASTES & GELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.4 Caps
6.3.1.4.1 Extended application of Infacaps for premature babies to propel segment
TABLE 40 CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.5 Batteries
6.3.1.5.1 Increasing usage of portable and rechargeable devices to support segment growth
TABLE 41 BATTERIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1.6 Cables
6.3.1.6.1 Technological developments for increasing capabilities and cable lifespan to drive segment
TABLE 42 CABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.7 Other accessories
TABLE 43 OTHER ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY
TABLE 44 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
6.3.2.1 Disposable accessories
6.3.2.1.1 Growing physician preference for disposable accessories to propel market
TABLE 45 DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2.2 Non-disposable accessories
6.3.2.2.1 Increased usage of reusable accessories in emerging economies to boost segment growth
TABLE 46 NON-DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 BRAIN MONITORING MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 47 BRAIN MONITORING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.1.1 NON-INVASIVE PROCEDURES
7.1.1.1 Limited risk of infections and hemorrhage to drive market
TABLE 48 BRAIN MONITORING MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
7.1.2 INVASIVE PROCEDURES
7.1.2.1 Higher resolution imaging and detailed disease information to propel market
TABLE 49 BRAIN MONITORING MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
8 BRAIN MONITORING MARKET, BY MODALITY
8.1 INTRODUCTION
TABLE 50 BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
8.2 FIXED DEVICES
8.2.1 HIGH ACCURACY, MORE RELIABILITY, AND BETTER DIAGNOSIS TO AID MARKET GROWTH
TABLE 51 BRAIN MONITORING MARKET FOR FIXED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 PORTABLE DEVICES
8.3.1 INCREASED MOBILITY AND COMFORT TO PROPEL MARKET GROWTH
TABLE 52 BRAIN MONITORING MARKET FOR PORTABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 WEARABLE DEVICES
8.4.1 GREATER CONVENIENCE AND CONTINUOUS DATA COLLECTION TO DRIVE MARKET GROWTH
TABLE 53 BRAIN MONITORING MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
9 BRAIN MONITORING MARKET, BY MEDICAL CONDITION
9.1 INTRODUCTION
TABLE 54 COMPANIES OFFERING DEVICES FOR DIFFERENT MEDICAL CONDITIONS
TABLE 55 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
9.2 TRAUMATIC BRAIN INJURY
9.2.1 GROWING INCIDENCE ACROSS ALL AGE GROUPS TO DRIVE MARKET
TABLE 56 BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 STROKE
9.3.1 GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH
TABLE 57 BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 DEMENTIA
9.4.1 FAVORABLE GOVERNMENT INITIATIVES AND INCREASED ACCESS TO TREATMENT TO DRIVE MARKET
TABLE 58 BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 HEADACHE DISORDERS
9.5.1 RISING NUMBER OF INITIATIVES FOR HEADACHE DISORDERS TO PROPEL MARKET
TABLE 59 BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 SLEEP DISORDERS
9.6.1 INCREASED STRESS AND UNHEALTHY LIFESTYLES AMONG ADULTS TO DRIVE MARKET
TABLE 60 BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.7 PARKINSON’S DISEASE
9.7.1 INCREASING GERIATRIC POPULATION TO AID MARKET GROWTH
TABLE 61 BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
9.8 EPILEPSY
9.8.1 RISING OCCURRENCE OF EPILEPSY AMONG ALL AGE GROUPS TO SUPPORT MARKET GROWTH
TABLE 62 BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2021–2028 (USD MILLION)
9.9 HUNTINGTON’S DISEASE
9.9.1 AVAILABILITY OF ADVANCED TREATMENT AND ONGOING RESEARCH TO AID MARKET GROWTH
TABLE 63 BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
9.10 OTHER MEDICAL CONDITIONS
TABLE 64 BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 BRAIN MONITORING MARKET, BY END USER
10.1 INTRODUCTION
TABLE 65 BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS
10.2.1 HOSPITALS TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
TABLE 66 BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 NEUROLOGY CENTERS
10.3.1 PRESENCE OF HIGHLY EFFICIENT AND ADVANCED BRAIN MONITORING DEVICES TO PROPEL MARKET
TABLE 67 BRAIN MONITORING MARKET FOR NEUROLOGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 DIAGNOSTIC CENTERS
10.4.1 FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF NEUROGENERATIVE DISORDERS TO SUPPORT MARKET GROWTH
TABLE 68 BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
10.5 AMBULATORY SURGERY CENTERS & CLINICS
10.5.1 COST-EFFECTIVE AND MORE CONVENIENT TREATMENT OPTIONS TO AID MARKET GROWTH
TABLE 69 BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
10.6 OTHER END USERS
TABLE 70 BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
11 BRAIN MONITORING MARKET, BY REGION
11.1 INTRODUCTION
TABLE 71 BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT
TABLE 72 NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 74 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 79 NORTH AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 80 NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 US to dominate North American brain monitoring market during forecast period
TABLE 82 US: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 83 US: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 US: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 87 US: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 88 US: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 89 US: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 90 US: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Increasing number of hospitals and surgical centers to propel market
TABLE 91 CANADA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 93 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CANADA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 96 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 97 CANADA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 CANADA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 99 CANADA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 EUROPE
FIGURE 39 EUROPE: BRAIN MONITORING MARKET SNAPSHOT
TABLE 100 EUROPE: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 106 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.1 EUROPE: RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Growing geriatric population and increasing life expectancy to aid market growth
TABLE 110 GERMANY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 111 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 115 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 116 GERMANY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 117 GERMANY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 118 GERMANY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increasing prevalence of neurological disorders to drive market
TABLE 119 FRANCE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 124 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 125 FRANCE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 126 FRANCE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 127 FRANCE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.4 UK
11.3.4.1 Increasing R&D investments by public and private sectors to boost market growth
TABLE 128 UK: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 UK: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 UK: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 133 UK: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 134 UK: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 135 UK: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 136 UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Rising incidence of neurological disorders in aging population to drive market
TABLE 137 ITALY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 138 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 ITALY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 142 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 143 ITALY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 144 ITALY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 145 ITALY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increased burden of Parkinson’s disease to propel market
TABLE 146 SPAIN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 147 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 SPAIN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 154 SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 155 REST OF EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 156 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 159 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 160 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 161 REST OF EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 162 REST OF EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 164 ASIA PACIFIC: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 172 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 173 ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.1 ASIA PACIFIC: RECESSION IMPACT
11.4.2 JAPAN
11.4.2.1 High incidence of neurological disorders and large geriatric population to drive market
TABLE 174 JAPAN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 175 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 JAPAN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 179 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 180 JAPAN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 181 JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 182 JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Increasing number of government initiatives and growing incidence of neurological disorders to drive market
TABLE 183 CHINA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 184 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 CHINA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 188 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 189 CHINA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 190 CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 191 CHINA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Improving healthcare infrastructure and rising public-private investment to support market growth
TABLE 192 INDIA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 193 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 INDIA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 197 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 198 INDIA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 199 INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 200 INDIA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 201 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 REST OF ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 LATIN AMERICA
TABLE 210 LATIN AMERICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 211 LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 212 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 216 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 217 LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 218 LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 219 LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.1 LATIN AMERICA: RECESSION IMPACT
11.5.2 BRAZIL
11.5.2.1 High cost of brain monitoring and imaging modalities to limit market growth
TABLE 220 BRAZIL: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 221 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 223 BRAZIL: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 224 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 225 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 226 BRAZIL: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 227 BRAZIL: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 228 BRAZIL: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Low tax rates and strong healthcare infrastructure to support market growth
TABLE 229 MEXICO: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 230 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 MEXICO: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 234 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 235 MEXICO: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 236 MEXICO: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 237 MEXICO: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 238 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 239 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 243 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 244 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 245 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 246 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
TABLE 247 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 249 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 253 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 254 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 255 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 256 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
11.6.2 GCC COUNTRIES
11.6.2.1 Rising prevalence of Alzheimer’s and increasing number of government initiatives to drive market
TABLE 257 GCC COUNTRIES: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 258 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 GCC COUNTRIES: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 262 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 263 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 264 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 265 GCC COUNTRIES: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 266 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 267 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 REST OF MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
TABLE 271 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 272 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 273 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
TABLE 274 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY STRATEGIES/RIGHT TO WIN
TABLE 275 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAIN MONITORING MARKET
12.3 REVENUE SHARE ANALYSIS
12.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 276 DEGREE OF COMPETITION IN BRAIN MONITORING MARKET
FIGURE 42 RANKING OF KEY COMPANIES IN BRAIN MONITORING MARKET, 2022
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 43 COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT
12.5.5.1 Overall footprint
TABLE 277 BRAIN MONITORING MARKET: OVERALL FOOTPRINT
12.5.5.2 Product footprint
TABLE 278 BRAIN MONITORING MARKET: PRODUCT FOOTPRINT
12.5.5.3 Procedure footprint
TABLE 279 BRAIN MONITORING MARKET: PROCEDURE FOOTPRINT
12.5.5.4 Modality footprint
TABLE 280 BRAIN MONITORING MARKET: MODALITY FOOTPRINT
12.5.5.5 Medical condition footprint
TABLE 281 BRAIN MONITORING MARKET: MEDICAL CONDITION FOOTPRINT
12.5.5.6 End user footprint
TABLE 282 BRAIN MONITORING MARKET: END USER FOOTPRINT
12.5.5.7 Regional footprint
TABLE 283 BRAIN MONITORING MARKET: REGIONAL FOOTPRINT
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 44 START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 284 DETAILED LIST OF KEY START-UPS/SMES IN BRAIN MONITORING MARKET
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 285 BRAIN MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2024
12.7.2 DEALS
TABLE 286 BRAIN MONITORING MARKET: DEALS, 2020–2024
12.7.3 OTHER DEVELOPMENTS
TABLE 287 BRAIN MONITORING MARKET: OTHER DEVELOPMENTS, 2020–2024
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 NATUS MEDICAL INCORPORATED
TABLE 289 NATUS MEDICAL INCORPORATED: DEALS, 2020–2024
13.1.2 NIHON KOHDEN CORPORATION
TABLE 290 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 291 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES &
APPROVALS, 2020–2024
13.1.3 PHILIPS HEALTHCARE
TABLE 292 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 293 PHILIPS HEALTHCARE: DEALS, 2020–2024
13.1.4 GE HEALTHCARE
TABLE 294 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 47 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 295 GE HEALTHCARE: DEALS, 2020–2024
13.1.5 SIEMENS HEALTHINEERS AG
TABLE 296 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 48 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
TABLE 297 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 298 SIEMENS HEALTHINEERS AG: DEALS, 2020–2024
13.1.6 COMPUMEDICS LIMITED
TABLE 299 COMPUMEDICS LIMITED: COMPANY OVERVIEW
FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)
TABLE 300 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 301 COMPUMEDICS LIMITED: DEALS, 2020–2024
13.1.7 MEDTRONIC
TABLE 302 MEDTRONIC: COMPANY OVERVIEW
FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2023)
13.1.8 EDWARDS LIFESCIENCES CORPORATION
TABLE 303 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 51 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
13.1.9 ADVANCED BRAIN MONITORING, INC.
TABLE 304 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW
13.1.10 CADWELL INDUSTRIES, INC.
TABLE 305 CADWELL INDUSTRIES, INC: COMPANY OVERVIEW
TABLE 306 CADWELL INDUSTRIES, INC.: PRODUCT LAUNCHES & APPROVALS, 2020–2024
TABLE 307 CADWELL INDUSTRIES, INC.: DEALS, 2020–2024
13.1.11 NEUROWAVE SYSTEMS, INC.
TABLE 308 NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW
13.1.12 NEUROSOFT
TABLE 309 NEUROSOFT: COMPANY OVERVIEW
13.1.13 CGX
TABLE 310 CGX: COMPANY OVERVIEW
TABLE 311 CGX: OTHER DEVELOPMENTS, 2020–2024
13.1.14 NONIN
TABLE 312 NONIN: COMPANY OVERVIEW
13.1.15 RIMED
TABLE 313 RIMED: COMPANY OVERVIEW
TABLE 314 RIMED: DEALS, 2020–2024
13.1.16 EMOTIV
TABLE 315 EMOTIV: COMPANY OVERVIEW
13.1.17 DRДGERWERK AG & CO. KGAA
TABLE 316 DRДGERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 52 DRДGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
13.1.18 MASIMO CORPORATION
TABLE 317 MASIMO CORPORATION: COMPANY OVERVIEW
FIGURE 53 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 318 MASIMO CORPORATION: DEALS, 2020–2024
13.1.19 LUCIOLE MEDICAL AG
TABLE 319 LUCIOLE MEDICAL AG: COMPANY OVERVIEW
TABLE 320 LUCIOLE MEDICAL AG: DEALS, 2020–2024
13.1.20 INTEGRA LIFESCIENCES
TABLE 321 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
FIGURE 54 INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022)
13.2 OTHER PLAYERS
13.2.1 INFRASCAN, INC.
13.2.2 NEUSOFT MEDICAL SYSTEMS CO., LTD.
13.2.3 NORAXON USA
13.2.4 STERNMED GMBH
13.2.5 CERIBELL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
